AI MARKET SCANNING

Erasca Inc

📅 Next Catalyst: Nov 11, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Health Technology 🏭 Pharmaceuticals Major
AVG HISTORICAL GAP +2.65%
MAX GAP RECORD +17.48%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ERAS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 11, 2026 Earnings Release 2026-11-11 (AFTER CLOSE) 🔮 UPCOMING 🔒
Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
+2.05%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
-2.11%
Mar 12, 2026 Earnings Release 2026-03-12 (AFTER CLOSE)
+3.41%
Nov 12, 2025 Earnings Release 2025-11-12 (AFTER CLOSE)
+0.00%
Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE)
-0.64%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
+2.26%
Mar 20, 2025 Earnings Release 2025-03-20 (AFTER CLOSE)
+0.00%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.9%
Bullish Gaps (8)
Bearish Gaps (2)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ERAS

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1072m +3.94%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗